Skip to main content

Find Clinical Trials

Home
Conditions
Primary Insomnia

Clinical trial condition

Primary Insomnia

Explore clinical trials studying Primary Insomnia. Study availability and eligibility vary by location and protocol.

71 public trials 2 recruiting studies

Refine in advanced search Browse all conditions

Primary Insomnia trial results

Completed

Mindfulness Versus Pharmacotherapy for Chronic Insomnia: A Pilot Study

NCT00515177

Conditions: Chronic Insomnia, Dyssomnias, Mental Disorders, +5 more
Locations: Minnesota Regional Sleep Disorders Center at Hennepin County Medical Center Minneapolis, Minnesota, United States

University of Minnesota Minneapolis, Minnesota, United States

View Trial Details

Completed

A Phase II/III Study of SEP-190 (Eszopiclone) in Patients With Primary Insomnia (Study 190-126)

NCT00770510

Conditions: Dyssomnias, Mental Disorders, Nervous System Diseases, +4 more
Locations: Toyohashi, Aichi-ken, Japan

Akita, Japan

Fukuoka, Japan

Kitakyushu, Fukuoka, Japan

View all 20 locations

View Trial Details

Completed

Study of Sleep-maintenance Activity of 3 Doses of SKP-1041

NCT00878553

Conditions: Dyssomnias, Mental Disorders, Nervous System Diseases, +8 more
Locations: Not specified

View Trial Details

Completed

Twelve Month Study of the Safety of Eszopiclone in Adult Subjects With Insomnia

NCT01710631

Conditions: Dyssomnias, Mental Disorders, Nervous System Diseases, +4 more
Locations: Not specified

View Trial Details

Completed

The Psychoneuroimmunology of Insomnia

NCT00680771

Conditions: Dyssomnias, Mental Disorders, Nervous System Diseases, +4 more
Locations: University of Rochester Sleep Research Laboratory Rochester, New York, United States

View Trial Details

Completed

A Dose-ranging, Multicenter Polysomnography Trial of PD 0200390 in Adults With Primary Insomnia

NCT00551148

Conditions: Dyssomnias, Mental Disorders, Nervous System Diseases, +4 more
Locations: Pfizer Investigational Site Glendale, Arizona, United States

Pfizer Investigational Site Phenoix, Arizona, United States

Pfizer Investigational Site Phoenix, Arizona, United States

Pfizer Investigational Site Tucson, Arizona, United States

View all 16 locations

View Trial Details

Completed

An Efficacy Study of Compound LY2624803 in the Treatment of Patients With Chronic Insomnia

NCT00784875

Conditions: Dyssomnias, Mental Disorders, Nervous System Diseases, +5 more
Locations: For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Birmingham, Alabama, United States

For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Glendale, Arizona, United States

For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Mesa, Arizona, United States

For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Little Rock, Arkansas, United States

View all 49 locations

View Trial Details

Completed

Effects of One Evening Dose of 3 mg Eszopiclone on Next Day Driving Ability

NCT00368056

Conditions: Dyssomnias, Mental Disorders, Nervous System Diseases, +4 more
Locations: HPRU Medical Research Centre, University of Surrey Guildford, Surrey, United Kingdom

View Trial Details

Completed

6-Month Chronic Efficacy & Safety Study of Eszopiclone in Adult Subjects With Primary Insomnia

NCT00352144

Conditions: Dyssomnias, Mental Disorders, Nervous System Diseases, +4 more
Locations: Birmingham, Alabama, United States

Huntsville, Alabama, United States

Phoenix, Arizona, United States

Scottsdale, Arizona, United States

View all 58 locations

View Trial Details

Completed

Safety and Efficacy of Chronic Hypnotic Use

NCT01006525

Conditions: Dyssomnias, Mental Disorders, Nervous System Diseases, +4 more
Locations: Henry Ford Sleep and Research Center Detroit, Michigan, United States

View Trial Details